Drug Information

Drug General Information
Drug ID
D06XCF
Former ID
DIB008130
Drug Name
EQ-917
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 2 [532274]
Company
Equispharm Co Ltd
Target and Pathway
Target(s) Toposisomerase-1 Target Info Inhibitor [530982]
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway DNA replication
Pathway Interaction Database Caspase Cascade in Apoptosis
WikiPathways Integrated Pancreatic Cancer Pathway
References
Ref 532274Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer. Lung Cancer. 2013 Jun;80(3):313-8.
Ref 530982The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer. J Chemother. 2010 Jun;22(3):197-200.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.